Immunization strategies against pulmonary Tuberculosis: Considerations of T cell geography

Advances in Experimental Medicine and Biology

Volumn 783, Issue , 2013, Pages 267-278

  Horvath, Carly N ^a   Xing, Zhou ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

"Vaccineless" boost strategies; Bacille Calmette Guerin (BCG) vaccine; Chemokines; Effector T cells; Genetic based vaccines; Human type 5 adenovirus (Ad5 vectored) vaccines; Lung interstitium; Mycobacterium Tuberculosis (M.tb); Subunit vaccines; T cell geography; Vesicular stomatitis virus based vaccines; Viral vectored TB vaccines

Indexed keywords

ADENOVIRUS VACCINE; BCG VACCINE; SUBUNIT VACCINE; RECOMBINANT VACCINE;

ARTICLE; BCG VACCINATION; DRUG EFFICACY; DRUG SAFETY; HOST; HUMAN; INFECTION PREVENTION; LUNG TUBERCULOSIS; MEDICAL GEOGRAPHY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; T LYMPHOCYTE; ANIMAL; ANTIBODY SPECIFICITY; CLASSIFICATION; GENE VECTOR; GENETICS; HEALTH; HUMAN ADENOVIRUS; IMMUNIZATION; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUNG; METHODOLOGY; MICROBIOLOGY; MOUSE; MUCOSAL IMMUNITY; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PREVALENCE; RESPIRATORY SYSTEM; REVIEW; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ADENOVIRUSES, HUMAN; ADMINISTRATION, INTRANASAL; ANIMALS; CHEMOTAXIS, LEUKOCYTE; GENETIC VECTORS; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; INJECTIONS, INTRAMUSCULAR; LUNG; MICE; MYCOBACTERIUM TUBERCULOSIS; ORGAN SPECIFICITY; PREVALENCE; RESPIRATORY SYSTEM; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY; VACCINATION; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; WORLD HEALTH;

MLCS; MLOWN;

EID: 84879522798     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-6111-1_14     Document Type: Article

References (43)

1. World Health Organization (2009) Global Tuberculosis control. World Health Organization, Geneva
2. Cooper AM (2009) T cells in mycobacterial infection and disease. Curr Opin Immunol 21(4):378-384
3. Cooper AM (2009) Cell-mediated immune responses in Tuberculosis. Annu Rev Immunol 27(1):393-422
4. Jeyanathan M, Heriazon A, Xing Z (2010) Airway luminal T cells: a newcomer on the stage of TB vaccination strategies. Trends Immunol 31(7):247-252
5. Xing Z (2009) Importance of T-cell location rekindled: Implication for Tuberculosis vaccination strategies. Expert Rev Vaccines 8(11):1465-1468
6. Ly LH, McMurray DN (2008) Tuberculosis: vaccines in the pipeline. Expert Rev Vaccines 7(5):635-650
7. Xing Z, Charters TJ (2007) Heterologous boost vaccines for bacillus Calmette-Guerin prime immunization against Tuberculosis. Expert Rev Vaccines 6(4):539-546
8. Parida SK, Kaufmann SH (2010) Novel Tuberculosis vaccines on the horizon. Curr Opin Immunol 22(3):374-384
9. Shaler C, Horvath C, Lai R, Xing Z (2012) Understanding delayed T cell priming, lung recruitment and airway luminal T cell responses in host defense against pulmonary Tuberculosis. Clin Dev Immunol 2012:628293
10. Horvath C, Shaler CR, Jeyanathan M, Zganiacz A, Xing Z (2012) Mechanisms of delayed anti-Tuberculosis protection in the lung of parenteral-BCG vaccinated hosts: a critical role of airway luminal T cells. Mucosal Immunol 5(4):420-431
11. Begum D et al (2009) Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium Tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette- Guérin. Immunology 128(4):556-563
12. McShane H et al (2001) Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine Tuberculosis. Infect Immun 69(2):681-686
13. Huygen K (2006) DNA vaccines against mycobacterial diseases. Future Microbiol 1(1): 63-73
14. Doherty TM et al (2004) Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium Tuberculosis. J Infect Dis 190(12):2146-2153
15. Zhang X et al (2007) Intramuscular immunization with a monogenic plasmid DNA Tuberculosis vaccine: enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Vaccine 25(7):1342-1352
16. Wang J et al (2004) Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary Tuberculosis. J Immunol 173(10):6357-6365
17. Goonetilleke NP et al (2003) Enhanced immunogenicity and protective efficacy against Mycobacterium Tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 171(3):1602-1609
18. Jeyanathan M et al (2008) Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA Tuberculosis vaccination: role of proinflammatory signals in the lung. J Immunol 181(8):5618-5626
19. Radosevic K et al (2007) Protective immune responses to a recombinant adenovirus type 35 Tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 75(8):4105-4115
20. Chen L et al (2004) Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary Tuberculosis. Infect Immun 72(1):238-246
21. Giri PK, Verma I, Khuller GK (2006) Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium Tuberculosis challenge in mice. J Infect 53(5):350-356
22. Garcia-Contreras L et al (2008) Immunization by a bacterial aerosol. Proc Nat Acad Sci U S A 105(12):4656-4660
23. Hubbard RD, Flory CM, Collins FM (1992) Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol 87(1):94-98
24. Coler RN et al (2001) Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium Tuberculosis. J immunol 166(10):6227-6235
25. Giri PK et al (2005) Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental Tuberculosis. FEMS Immunol Med Microbiol 45(1):87-93
26. Xing Z, Lichty BD (2006) Use of recombinant virus-vectored Tuberculosis vaccines for respiratory mucosal immunization. Tuberculosis 86(3-4):211-217
27. Lasaro MO, Ertl HC (2009) New insights on adenovirus as vaccine vectors. Mol Ther 17(8):1333-1339
28. Santosuosso M et al (2005) Mechanisms of mucosal and parenteral Tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J Immunol 174(12): 7986-7994
29. Jeyanathan M et al (2010) Murine airway luminal antiTuberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment. Am J Respir Crit Care Med 181(8):862-872
30. Mu J, Jeyanathan M, Shaler CR, Horvath C, Damjanovic D, Zganiacz A, Kugathasan K, McCormick S, Xing Z (2010) Respiratory mucosal immunization with adenovirus gene transfer vector induces helper CD4 T cell-independent protective immunity. J Gene Med 12:693-704
31. Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G, Vogels R, Skeiky YA, Hone DM, Sadoff JC, van der Poll T, Havenga M, Goudsmit J (2007) Protective immune responses to a recombinant adenovirus type 35 Tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 75(8):4105-4115
32. Roediger EK, Kugathasan K, Zhang X, Lichty BD, Xing Z (2008) Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus vectored vaccine for pulmonary Tuberculosis. Mol Ther 16:1161-1169
33. Dietrich J, Andersen C, Rappuoli R, Doherty TM, Jensen CG, Andersen P (2006) Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium Tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immunol 177(9): 6353-6360
34. Andersen CS, Dietrich J, Agger EM, Lycke NY, Lovgren K, Andersen P (2007) The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium Tuberculosis. Infect Immun 75(1):408-416
35. Haile M et al (2005) Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice. Tuberculosis 85 (1-2):107-114
36. Gilbert SC et al (2006) Synergistic DNA-MVA prime-boost vaccination regimes for malaria and Tuberculosis. Vaccine 24(21):4554-4561
37. Santosuosso M et al (2006) Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary Tuberculosis. Infect Immun 74(8):4634-4643
38. Forbes EK et al (2008) Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium Tuberculosis aerosol challenge in mice. J Immunol 181(7):4955-4964
39. Ronan EO, Lee LN, Beverley PC, Tchilian EZ (2009) Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium Tuberculosis after infection. PLoS ONE 4(12):e8235
40. Xing Z, McFarland CT, Sallenave JM, Izzo A, Wang J, McMurray DN (2009) Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed uinea pigs against pulmonary Tuberculosis. PLoS ONE 4(6):e5856
41. Tchilian EZ, Ronan EO, de Lara C, Lee LN, Franken KL, Vordermeier MH, Ottenhoff TH, Beverley PC (2011) Simultaneous immunization against Tuberculosis. PLoS ONE 6(11):e27477
42. Santosuosso M et al (2007) Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization. J Immunol 178(4):2387-2395
43. Wooley J (2011) Tuberculosis vaccine candidates2011. Stop TB Partnership. Available via Tuberculosis Vaccine Initiative. http://www.tbvi.eu/fileadmin/ user-upload/Documenten/News/TB-Vaccine-Pipeline-2011-FINAL03042012.pdf. Accessed August 2012